Safety and efficacy study using ABT-335 [Choline fenofibrate] (investigational drug) in combination with atorvastatin, to study the effects on thickening of the blood vessel wall in patients with abnormal lipid (fat) levels in the blood (FIRST).

Trial Profile

Safety and efficacy study using ABT-335 [Choline fenofibrate] (investigational drug) in combination with atorvastatin, to study the effects on thickening of the blood vessel wall in patients with abnormal lipid (fat) levels in the blood (FIRST).

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2014

At a glance

  • Drugs Choline fenofibrate (Primary) ; Atorvastatin
  • Indications Dyslipidaemias
  • Focus Pharmacodynamics; Registrational
  • Acronyms FIRST
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 10 Mar 2013 Primary endpoint 'Intima-media-thickness' has not been met.
    • 10 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
    • 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top